106621,Admission,O
106621,Date,O
106621,:,O
106621,[,O
106621,**2167-8-29**,O
106621,],O
106621,Discharge,O
106621,Date,O
106621,:,O
106621,[,O
106621,**2167-9-9**,O
106621,],O
106621,Date,O
106621,of,O
106621,Birth,O
106621,:,O
106621,[,O
106621,**2096-2-18**,O
106621,],O
106621,Sex,O
106621,:,O
106621,M,O
106621,Service,O
106621,:,O
106621,MEDICINE,O
106621,Allergies,O
106621,:,O
106621,Bactrim,B-Drug
106621,/,O
106621,Penicillins,B-Drug
106621,Attending,O
106621,:,O
106621,[,O
106621,**First,O
106621,Name3,O
106621,(,O
106621,LF,O
106621,),O
106621,6169**,O
106621,],O
106621,Chief,O
106621,Complaint,O
106621,:,O
106621,altered,O
106621,mental,O
106621,status,O
106621,;,O
106621,transfer,O
106621,from,O
106621,MICU,O
106621,Major,O
106621,Surgical,O
106621,or,O
106621,Invasive,O
106621,Procedure,O
106621,:,O
106621,intubation,O
106621,;,O
106621,now,O
106621,s/p,O
106621,extubation,O
106621,History,O
106621,of,O
106621,Present,O
106621,Illness,O
106621,:,O
106621,71M,O
106621,with,O
106621,multiple,B-Reason
106621,myeloma,I-Reason
106621,currently,O
106621,on,O
106621,Velcade,B-Drug
106621,",",I-Drug
106621,mixed,O
106621,obstructive-restrictive,O
106621,lung,O
106621,disease,O
106621,",",O
106621,PAF,O
106621,",",O
106621,presented,O
106621,to,O
106621,the,O
106621,ED,O
106621,on,O
106621,[,O
106621,**2167-8-29**,O
106621,],O
106621,complaining,O
106621,of,O
106621,polyuria,O
106621,.,O
106621,Per,O
106621,sister,O
106621,",",O
106621,patient,O
106621,has,O
106621,been,O
106621,fatigued,O
106621,with,O
106621,poor,O
106621,po,O
106621,intake,O
106621,for,O
106621,several,O
106621,weeks,O
106621,.,O
106621,She,O
106621,is,O
106621,not,O
106621,aware,O
106621,of,O
106621,any,O
106621,acute,O
106621,changes,O
106621,in,O
106621,his,O
106621,health,O
106621,.,O
106621,She,O
106621,took,O
106621,him,O
106621,to,O
106621,his,O
106621,Velcade,B-Drug
106621,appointment,O
106621,on,O
106621,Friday,O
106621,",",O
106621,where,O
106621,he,O
106621,felt,O
106621,fatigued,B-ADE
106621,but,O
106621,was,O
106621,of,O
106621,normal,O
106621,mood,O
106621,and,O
106621,behavior,O
106621,.,O
106621,He,O
106621,received,O
106621,day,O
106621,4,O
106621,of,O
106621,his,O
106621,Velcade,B-Drug
106621,at,O
106621,this,O
106621,time,O
106621,as,O
106621,well,O
106621,as,O
106621,1u,B-Dosage
106621,PRBCs,O
106621,.,O
106621,.,O
106621,His,O
106621,VS,O
106621,on,O
106621,presentation,O
106621,to,O
106621,the,O
106621,ED,O
106621,were,O
106621,T,O
106621,99.6,O
106621,",",O
106621,HR,O
106621,68,O
106621,",",O
106621,BP,O
106621,106/56,O
106621,",",O
106621,RR,O
106621,25,O
106621,",",O
106621,O2sat,O
106621,97,O
106621,%,O
106621,RA,O
106621,.,O
106621,His,O
106621,K,B-Reason
106621,was,I-Reason
106621,6.0,I-Reason
106621,",",I-Reason
106621,so,O
106621,he,O
106621,was,O
106621,given,O
106621,Kayexalate,B-Drug
106621,30g,O
106621,.,O
106621,On,O
106621,exam,O
106621,",",O
106621,he,O
106621,had,O
106621,RUQ,O
106621,tenderness,O
106621,with,O
106621,a,O
106621,normal,O
106621,RUQ,O
106621,ultrasound,O
106621,.,O
106621,He,O
106621,was,O
106621,also,O
106621,noted,O
106621,to,O
106621,be,O
106621,somewhat,O
106621,dyspneic,O
106621,with,O
106621,an,O
106621,elevated,O
106621,D-dimer,O
106621,so,O
106621,he,O
106621,was,O
106621,sent,O
106621,for,O
106621,a,O
106621,V/Q,O
106621,scan,O
106621,to,O
106621,rule,O
106621,out,O
106621,a,O
106621,PE,O
106621,.,O
106621,.,O
106621,Halfway,O
106621,through,O
106621,the,O
106621,scan,O
106621,",",O
106621,he,O
106621,became,O
106621,agitated,O
106621,and,O
106621,combative,O
106621,and,O
106621,had,O
106621,stool,O
106621,incontinence,O
106621,.,O
106621,His,O
106621,VS,O
106621,upon,O
106621,return,O
106621,were,O
106621,HR,O
106621,110,O
106621,",",O
106621,BP,O
106621,144/65,O
106621,",",O
106621,O2sat,O
106621,89,O
106621,%,O
106621,NRB,O
106621,.,O
106621,He,O
106621,was,O
106621,dyspneic,O
106621,",",O
106621,diaphoretic,O
106621,",",O
106621,and,O
106621,nonverbal,O
106621,.,O
106621,He,O
106621,was,O
106621,given,O
106621,Ativan,B-Drug
106621,1mg,O
106621,IV,O
106621,for,O
106621,agitation,B-Reason
106621,.,I-Reason
106621,On,O
106621,lung,O
106621,exam,O
106621,",",O
106621,he,O
106621,had,O
106621,very,O
106621,poor,O
106621,air,O
106621,movement,O
106621,.,O
106621,He,O
106621,was,O
106621,intubated,O
106621,in,O
106621,the,O
106621,ED,O
106621,for,O
106621,airway,O
106621,protection,O
106621,with,O
106621,altered,O
106621,mental,O
106621,status,O
106621,and,O
106621,hypoxic,O
106621,respiratory,O
106621,failure,O
106621,.,O
106621,CXR,O
106621,showed,O
106621,clear,O
106621,lungs,O
106621,.,O
106621,He,O
106621,was,O
106621,given,O
106621,Solumedrol,B-Drug
106621,125mg,O
106621,IV,O
106621,",",O
106621,Benadryl,B-Drug
106621,50mg,O
106621,IV,O
106621,",",O
106621,and,O
106621,Pepcid,B-Drug
106621,20mg,O
106621,IV,O
106621,to,O
106621,treat,O
106621,possible,O
106621,allergic,B-Reason
106621,reaction,I-Reason
106621,to,O
106621,the,O
106621,radionuclide,B-Drug
106621,material,I-Drug
106621,.,I-Drug
106621,He,O
106621,was,O
106621,also,O
106621,started,O
106621,on,O
106621,a,O
106621,propofol,B-Drug
106621,gtt,O
106621,for,O
106621,sedation,B-Reason
106621,and,O
106621,2L,B-Dosage
106621,NS,O
106621,.,O
106621,He,O
106621,was,O
106621,admitted,O
106621,to,O
106621,the,O
106621,MICU,O
106621,for,O
106621,further,O
106621,management,O
106621,.,O
106621,.,O
106621,In,O
106621,the,O
106621,MICU,O
106621,",",O
106621,he,O
106621,was,O
106621,quickly,O
106621,weaned,O
106621,off,O
106621,of,O
106621,the,O
106621,ventilator,O
106621,and,O
106621,on,O
106621,to,O
106621,a,O
106621,nasal,O
106621,cannula,O
106621,at,O
106621,2L/min,O
106621,on,O
106621,the,O
106621,morning,O
106621,of,O
106621,[,O
106621,**2167-8-31**,O
106621,],O
106621,.,O
106621,His,O
106621,mental,O
106621,status,O
106621,remained,O
106621,somewhat,O
106621,impaired,O
106621,in,O
106621,that,O
106621,he,O
106621,was,O
106621,never,O
106621,fully,O
106621,oriented,O
106621,to,O
106621,place,O
106621,.,O
106621,He,O
106621,had,O
106621,2,O
106621,sets,O
106621,of,O
106621,blood,O
106621,cultures,O
106621,sent,O
106621,(,O
106621,though,O
106621,it,O
106621,'s,O
106621,unclear,O
106621,if,O
106621,he,O
106621,was,O
106621,ever,O
106621,febrile,O
106621,),O
106621,and,O
106621,grew,B-Reason
106621,gram,I-Reason
106621,(,I-Reason
106621,+,I-Reason
106621,),I-Reason
106621,cocci,I-Reason
106621,in,I-Reason
106621,pairs/clusters,I-Reason
106621,from,O
106621,3/4,O
106621,bottles,O
106621,;,O
106621,he,O
106621,was,O
106621,started,O
106621,on,O
106621,vancomycin,B-Drug
106621,.,I-Drug
106621,His,O
106621,sputum,O
106621,culture,O
106621,also,O
106621,had,O
106621,4+,O
106621,gram,O
106621,(,O
106621,+,O
106621,),O
106621,cocci,O
106621,in,O
106621,pairs/chains,O
106621,.,O
106621,His,O
106621,warfarin,B-Drug
106621,was,O
106621,initially,O
106621,held,O
106621,due,O
106621,to,O
106621,the,O
106621,possibility,O
106621,of,O
106621,an,O
106621,LP,O
106621,but,O
106621,this,O
106621,was,O
106621,never,O
106621,done,O
106621,since,O
106621,his,O
106621,mental,O
106621,status,O
106621,seemed,O
106621,to,O
106621,be,O
106621,improving,O
106621,.,O
106621,Past,O
106621,Medical,O
106621,History,O
106621,:,O
106621,Oncologic,O
106621,History,O
106621,:,O
106621,Multiple,B-Reason
106621,myeloma,I-Reason
106621,diagnosed,O
106621,in,O
106621,[,O
106621,**12/2164**,O
106621,],O
106621,after,O
106621,presenting,O
106621,with,O
106621,several,O
106621,months,O
106621,of,O
106621,diffuse,O
106621,bony,O
106621,pain,O
106621,;,O
106621,found,O
106621,to,O
106621,have,O
106621,numerous,O
106621,lytic,O
106621,bony,O
106621,lesions,O
106621,and,O
106621,a,O
106621,monocloncal,O
106621,kappa,O
106621,protein,O
106621,in,O
106621,his,O
106621,UPEP,O
106621,(,O
106621,>,O
106621,8,O
106621,grams,O
106621,of,O
106621,kappa,O
106621,proteinuria,O
106621,),O
106621,;,O
106621,diagnosed,O
106621,with,O
106621,stage,O
106621,IIIB,O
106621,kappa,O
106621,light,O
106621,chain,O
106621,multiple,O
106621,myeloma,O
106621,.,O
106621,He,O
106621,initially,O
106621,responded,O
106621,well,O
106621,to,O
106621,Decadron,B-Drug
106621,and,O
106621,was,O
106621,then,O
106621,intolerant,O
106621,to,O
106621,thalidomide/,B-Drug
106621,Decadron,O
106621,;,O
106621,he,O
106621,subsequently,O
106621,responded,O
106621,well,O
106621,to,O
106621,Cytoxan/,B-Drug
106621,Decadron,O
106621,with,O
106621,a,O
106621,marked,O
106621,decrease,O
106621,in,O
106621,his,O
106621,kappa,O
106621,excretion,O
106621,and,O
106621,improvement,O
106621,inhis,O
106621,renal,O
106621,function,O
106621,.,O
106621,In,O
106621,[,O
106621,**7-/2165**,O
106621,],O
106621,",",O
106621,he,O
106621,underwent,O
106621,an,O
106621,autologous,O
106621,SCT,O
106621,after,O
106621,treatment,O
106621,with,O
106621,high-dose,B-Dosage
106621,melphalan,O
106621,.,O
106621,He,O
106621,went,O
106621,into,O
106621,remission,O
106621,at,O
106621,this,O
106621,time,O
106621,which,O
106621,he,O
106621,maintained,O
106621,until,O
106621,[,O
106621,**7-/2167**,O
106621,],O
106621,when,O
106621,he,O
106621,presented,O
106621,to,O
106621,the,O
106621,ED,O
106621,with,O
106621,dyspnea,O
106621,on,O
106621,exertion,O
106621,;,O
106621,he,O
106621,was,O
106621,found,O
106621,to,O
106621,have,O
106621,20,O
106621,grams,O
106621,of,O
106621,Bence,O
106621,[,O
106621,**Doctor,O
106621,Last,O
106621,Name,O
106621,**,O
106621,],O
106621,proteinuria,O
106621,and,O
106621,new,O
106621,diabetes,O
106621,insipidus,O
106621,.,O
106621,A,O
106621,bone,O
106621,marrow,O
106621,biopsy,O
106621,showed,O
106621,>,O
106621,60,O
106621,%,O
106621,plasma,O
106621,cells,O
106621,.,O
106621,He,O
106621,was,O
106621,pulsed,O
106621,with,O
106621,Decadron,B-Drug
106621,and,O
106621,discharged,O
106621,on,O
106621,po,B-Route
106621,Decadron,O
106621,for,O
106621,his,O
106621,MM,B-Reason
106621,and,O
106621,intranasal,B-Route
106621,ddAVP,O
106621,for,O
106621,his,O
106621,DI,B-Reason
106621,.,I-Reason
106621,On,O
106621,[,O
106621,**2167-8-25**,O
106621,],O
106621,",",O
106621,he,O
106621,was,O
106621,started,O
106621,on,O
106621,Velcade,B-Drug
106621,(,O
106621,in,O
106621,addition,O
106621,to,O
106621,his,O
106621,[,O
106621,**Hospital1,O
106621,**,O
106621,],O
106621,Decadron,B-Drug
106621,),I-Drug
106621,.,O
106621,He,O
106621,received,O
106621,days,O
106621,1,O
106621,and,O
106621,4,O
106621,of,O
106621,Velcade,B-Drug
106621,prior,O
106621,to,O
106621,this,O
106621,presentation,O
106621,.,O
106621,.,O
106621,.,O
106621,PMH,O
106621,:,O
106621,1,O
106621,.,O
106621,Multiple,B-Reason
106621,myeloma,I-Reason
106621,?,I-Reason
106621,?,O
106621,?,O
106621,?,O
106621,?,O
106621,?,O
106621,Stage,O
106621,IIIA,O
106621,with,O
106621,kappa,O
106621,light,O
106621,chains,O
106621,",",O
106621,diagnosed,O
106621,in,O
106621,[,O
106621,**12-27**,O
106621,],O
106621,.,O
106621,Extensive,O
106621,lytic,O
106621,bone,O
106621,lesions,O
106621,(,O
106621,mostly,O
106621,in,O
106621,pelvis,O
106621,and,O
106621,legs,O
106621,),O
106621,without,O
106621,renal,O
106621,involvement,O
106621,.,O
106621,s/p,O
106621,autologous,O
106621,stem,O
106621,cell,O
106621,transplantation,O
106621,in,O
106621,[,O
106621,**7-27**,O
106621,],O
106621,.,O
106621,Was,O
106621,in,O
106621,remission,O
106621,with,O
106621,Zometa,B-Drug
106621,qo,O
106621,month,O
106621,until,O
106621,[,O
106621,**8-18**,O
106621,],O
106621,when,O
106621,he,O
106621,had,O
106621,a,O
106621,marrow,O
106621,biopsy,O
106621,showing,O
106621,relapse,O
106621,.,O
106621,Started,O
106621,on,O
106621,Velcade,B-Drug
106621,on,O
106621,[,O
106621,**8-25**,O
106621,],O
106621,(,O
106621,last,O
106621,dose,O
106621,10/6,O
106621,),O
106621,.,O
106621,Followed,O
106621,by,O
106621,Dr,O
106621,[,O
106621,**First,O
106621,Name,O
106621,(,O
106621,STitle,O
106621,),O
106621,1557**,O
106621,],O
106621,.,O
106621,Baseline,O
106621,creatinine,O
106621,1.9-2.0,O
106621,.,O
106621,2,O
106621,.,O
106621,Diabetes,B-Reason
106621,insipidus-,I-Reason
106621,dx,O
106621,during,O
106621,[,O
106621,**7-29**,O
106621,],O
106621,hosp.,O
106621,",",O
106621,+,O
106621,water,O
106621,deprivation,O
106621,test,O
106621,and,O
106621,response,O
106621,to,O
106621,ddAVP,B-Drug
106621,(,O
106621,thus,O
106621,",",O
106621,likely,O
106621,central,O
106621,),O
106621,3,O
106621,.,O
106621,Hypertension,O
106621,4,O
106621,.,O
106621,Restrictive/Obstructive,O
106621,lung,O
106621,disease,O
106621,:,O
106621,Followed,O
106621,by,O
106621,Dr.,O
106621,[,O
106621,**Last,O
106621,Name,O
106621,(,O
106621,STitle,O
106621,),O
106621,**,O
106621,],O
106621,.,O
106621,5,O
106621,.,O
106621,Paroxysmal,B-Reason
106621,AFib-,I-Reason
106621,on,O
106621,Coumadin,B-Drug
106621,and,O
106621,rate-controlled,O
106621,6,O
106621,.,O
106621,Hypercholesterolemia,O
106621,7,O
106621,.,O
106621,Osteoarthritis,O
106621,s/p,O
106621,bilateral,O
106621,knee,O
106621,replacements,O
106621,in,O
106621,[,O
106621,**2160**,O
106621,],O
106621,",",O
106621,[,O
106621,**2161**,O
106621,],O
106621,8,O
106621,.,O
106621,MVA,O
106621,[,O
106621,**2147**,O
106621,],O
106621,--,O
106621,>,O
106621,Multiple,O
106621,bilateral,O
106621,fractured,O
106621,ribs,O
106621,",",O
106621,lumbar,O
106621,diskectomy,O
106621,.,O
106621,Social,O
106621,History,O
106621,:,O
106621,The,O
106621,patient,O
106621,is,O
106621,divorced,O
106621,.,O
106621,He,O
106621,currently,O
106621,lives,O
106621,alone,O
106621,.,O
106621,He,O
106621,has,O
106621,no,O
106621,children,O
106621,.,O
106621,He,O
106621,has,O
106621,a,O
106621,sister,O
106621,who,O
106621,lives,O
106621,nearby,O
106621,.,O
106621,Both,O
106621,he,O
106621,and,O
106621,his,O
106621,sister,O
106621,live,O
106621,in,O
106621,Mission,O
106621,[,O
106621,**Doctor,O
106621,Last,O
106621,Name,O
106621,**,O
106621,],O
106621,.,O
106621,He,O
106621,has,O
106621,another,O
106621,sister,O
106621,who,O
106621,lives,O
106621,in,O
106621,[,O
106621,**Name,O
106621,(,O
106621,NI,O
106621,),O
106621,15076**,O
106621,],O
106621,",",O
106621,who,O
106621,will,O
106621,be,O
106621,staying,O
106621,with,O
106621,him,O
106621,during,O
106621,his,O
106621,transplant,O
106621,recovery,O
106621,to,O
106621,help,O
106621,assist,O
106621,with,O
106621,meals,O
106621,and,O
106621,housekeeping,O
106621,.,O
106621,Retired,O
106621,meatworker,O
106621,originally,O
106621,from,O
106621,[,O
106621,**Doctor,O
106621,Last,O
106621,Name,O
106621,15076**,O
106621,],O
106621,with,O
106621,extensive,O
106621,travel,O
106621,history,O
106621,.,O
106621,Occ,O
106621,EtOH,O
106621,.,O
106621,No,O
106621,tobacco,O
106621,Family,O
106621,History,O
106621,:,O
106621,No,O
106621,known,O
106621,family,O
106621,history,O
106621,of,O
106621,cancer,O
106621,",",O
106621,hypertension,O
106621,",",O
106621,or,O
106621,DM,O
106621,.,O
106621,Mother,O
106621,died,O
106621,at,O
106621,36,O
106621,and,O
106621,father,O
106621,at,O
106621,65,O
106621,of,O
106621,unknown,O
106621,causes,O
106621,.,O
106621,Brother,O
106621,and,O
106621,sisters,O
106621,have,O
106621,heart,O
106621,disease,O
106621,.,O
106621,Physical,O
106621,Exam,O
106621,:,O
106621,PHYSICAL,O
106621,EXAM,O
106621,(,O
106621,upon,O
106621,transfer,O
106621,out,O
106621,of,O
106621,MICU,O
106621,),O
106621,:,O
106621,T,O
106621,97.7,O
106621,HR,O
106621,62,O
106621,BP,O
106621,137/76,O
106621,Sat,O
106621,96,O
106621,%,O
106621,2L,O
106621,Weight,O
106621,156.2,O
106621,lbs,O
106621,Gen,O
106621,:,O
106621,elderly,O
106621,man,O
106621,in,O
106621,NAD,O
106621,",",O
106621,intermittently,O
106621,somnolent,O
106621,HEENT,O
106621,:,O
106621,no,O
106621,obvious,O
106621,trauma,O
106621,",",O
106621,OP,O
106621,dry,O
106621,with,O
106621,no,O
106621,lesions,O
106621,Neck,O
106621,:,O
106621,JVP,O
106621,flat,O
106621,with,O
106621,no,O
106621,carotid,O
106621,bruits,O
106621,Pulm,O
106621,:,O
106621,poor,O
106621,inspiratory,O
106621,effort,O
106621,",",O
106621,no,O
106621,wheezes/rales/ronchi,O
106621,heard,O
106621,CV,O
106621,:,O
106621,regularly,O
106621,irregular,O
106621,",",O
106621,nl,O
106621,s1s2,O
106621,",",O
106621,no,O
106621,m/r/g,O
106621,Abd,O
106621,:,O
106621,soft,O
106621,",",O
106621,nondistended,O
106621,",",O
106621,moderate,O
106621,tenderness,O
106621,to,O
106621,deep,O
106621,palpation,O
106621,in,O
106621,RUQ,O
106621,",",O
106621,no,O
106621,[,O
106621,**Doctor,O
106621,Last,O
106621,Name,O
106621,515**,O
106621,],O
106621,",",O
106621,nl,O
106621,BS,O
106621,",",O
106621,tympanitic,O
106621,",",O
106621,no,O
106621,hepatosplenomegaly/masses,O
106621,",",O
106621,no,O
106621,rebound/guarding,O
106621,Extr,O
106621,:,O
106621,no,O
106621,clubbing,O
106621,",",O
106621,cyanosis,O
106621,",",O
106621,or,O
106621,edema,O
106621,;,O
106621,cool,O
106621,feet,O
106621,Skin,O
106621,:,O
106621,dry,O
106621,",",O
106621,cool,O
106621,",",O
106621,scaling,O
106621,;,O
106621,no,O
106621,rashes/breakdown,O
106621,Neuro,O
106621,:,O
106621,alert,O
106621,but,O
106621,mildly,O
106621,somnolent,O
106621,;,O
106621,oriented,O
106621,to,O
106621,self,O
106621,",",O
106621,``,O
106621,[,O
106621,**Month,O
106621,(,O
106621,only,O
106621,),O
106621,**,O
106621,],O
106621,[,O
106621,**2166**,O
106621,],O
106621,'',O
106621,",",O
106621,and,O
106621,oriented,O
106621,to,O
106621,``,O
106621,hospital,O
106621,'',O
106621,only,O
106621,when,O
106621,given,O
106621,choices,O
106621,;,O
106621,CN,O
106621,[,O
106621,**1-4**,O
106621,],O
106621,intact,O
106621,;,O
106621,5/5,O
106621,strength,O
106621,in,O
106621,all,O
106621,extremities,O
106621,Pertinent,O
106621,Results,O
106621,:,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,NEUTS-84.7*,O
106621,BANDS-0,O
106621,LYMPHS-10.4*,O
106621,MONOS-3.8,O
106621,EOS-1.0,O
106621,BASOS-0.1,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,WBC-7.2,O
106621,RBC-2.91*,O
106621,HGB-9.0*,O
106621,HCT-27.5*,O
106621,MCV-95,O
106621,MCH-30.9,O
106621,MCHC-32.6,O
106621,RDW-18.6*,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,IgG-376*,O
106621,IgA-32*,O
106621,IgM-13*,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,ALBUMIN-3.8,O
106621,PHOSPHATE-3.3,O
106621,MAGNESIUM-2.4,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,ALT,O
106621,(,O
106621,SGPT,O
106621,),O
106621,-58*,O
106621,AST,O
106621,(,O
106621,SGOT,O
106621,),O
106621,-33,O
106621,LD,O
106621,(,O
106621,LDH,O
106621,),O
106621,-504*,O
106621,ALK,O
106621,PHOS-83,O
106621,TOT,O
106621,BILI-0.2,O
106621,DIR,O
106621,BILI-0.1,O
106621,INDIR,O
106621,BIL-0.1,O
106621,[,O
106621,**2167-8-28**,O
106621,],O
106621,01:10PM,O
106621,GLUCOSE-116*,O
106621,UREA,O
106621,N-44*,O
106621,CREAT-1.6*,O
106621,SODIUM-143,O
106621,POTASSIUM-5.5*,O
106621,CHLORIDE-105,O
106621,TOTAL,O
106621,CO2-31,O
106621,ANION,O
106621,GAP-13,O
106621,[,O
106621,**2167-8-29**,O
106621,],O
106621,02:55PM,O
106621,ALT,O
106621,(,O
106621,SGPT,O
106621,),O
106621,-67*,O
106621,AST,O
106621,(,O
106621,SGOT,O
106621,),O
106621,-212*,O
106621,ALK,O
106621,PHOS-79,O
106621,AMYLASE-46,O
106621,TOT,O
106621,BILI-0.2,O
106621,[,O
106621,**2167-8-29**,O
106621,],O
106621,02:55PM,O
106621,GLUCOSE-174*,O
106621,UREA,O
106621,N-50*,O
106621,CREAT-1.5*,O
106621,SODIUM-138,O
106621,POTASSIUM-6.0*,O
106621,CHLORIDE-103,O
106621,TOTAL,O
106621,CO2-28,O
106621,ANION,O
106621,GAP-13,O
106621,[,O
106621,**2167-8-29**,O
106621,],O
106621,10:45PM,O
106621,TYPE-ART,O
106621,TIDAL,O
106621,VOL-550,O
106621,PO2-461*,O
106621,PCO2-48*,O
106621,PH-7.32*,O
106621,TOTAL,O
106621,CO2-26,O
106621,BASE,O
106621,XS,O
106621,--,O
106621,1,O
106621,INTUBATED-INTUBATED,O
106621,VENT-CONTROLLED,O
106621,Brief,O
106621,Hospital,O
106621,Course,O
106621,:,O
106621,In,O
106621,the,O
106621,MICU,O
106621,",",O
106621,he,O
106621,was,O
106621,quickly,O
106621,weaned,O
106621,off,O
106621,of,O
106621,the,O
106621,ventilator,O
106621,and,O
106621,on,O
106621,to,O
106621,a,O
106621,nasal,O
106621,cannula,O
106621,at,O
106621,2L/min,O
106621,on,O
106621,the,O
106621,morning,O
106621,of,O
106621,[,O
106621,**2167-8-31**,O
106621,],O
106621,.,O
106621,His,O
106621,mental,O
106621,status,O
106621,remained,O
106621,somewhat,O
106621,impaired,O
106621,in,O
106621,that,O
106621,he,O
106621,was,O
106621,never,O
106621,fully,O
106621,oriented,O
106621,to,O
106621,place,O
106621,.,O
106621,He,O
106621,had,O
106621,2,O
106621,sets,O
106621,of,O
106621,blood,O
106621,cultures,O
106621,sent,O
106621,(,O
106621,though,O
106621,it,O
106621,'s,O
106621,unclear,O
106621,if,O
106621,he,O
106621,was,O
106621,ever,O
106621,febrile,O
106621,),O
106621,and,O
106621,grew,O
106621,gram,B-Reason
106621,(,I-Reason
106621,+,I-Reason
106621,),I-Reason
106621,cocci,I-Reason
106621,in,I-Reason
106621,pairs/clusters,I-Reason
106621,from,O
106621,3/4,O
106621,bottles,O
106621,;,O
106621,he,O
106621,was,O
106621,started,O
106621,on,O
106621,vancomycin,B-Drug
106621,.,I-Drug
106621,His,O
106621,sputum,O
106621,culture,O
106621,also,O
106621,had,O
106621,4+,O
106621,gram,O
106621,(,O
106621,+,O
106621,),O
106621,cocci,O
106621,in,O
106621,pairs/chains,O
106621,.,O
106621,His,O
106621,warfarin,B-Drug
106621,was,O
106621,initially,O
106621,held,O
106621,due,O
106621,to,O
106621,the,O
106621,possibility,O
106621,of,O
106621,an,O
106621,LP,O
106621,but,O
106621,this,O
106621,was,O
106621,never,O
106621,done,O
106621,since,O
106621,his,O
106621,mental,O
106621,status,O
106621,seemed,O
106621,to,O
106621,be,O
106621,improving,O
106621,.,O
106621,.,O
106621,Upon,O
106621,transfer,O
106621,to,O
106621,the,O
106621,floor,O
106621,:,O
106621,.,O
106621,A/P,O
106621,:,O
106621,71M,O
106621,with,O
106621,multiple,O
106621,myeloma,O
106621,",",O
106621,mixed,O
106621,obstructive-restrictive,O
106621,lung,O
106621,disease,O
106621,",",O
106621,?,O
106621,DI,O
106621,",",O
106621,and,O
106621,PAF,O
106621,",",O
106621,admitted,O
106621,after,O
106621,acute,O
106621,episode,O
106621,of,O
106621,altered,O
106621,mental,O
106621,status,O
106621,(,O
106621,of,O
106621,unclear,O
106621,etiology,O
106621,),O
106621,now,O
106621,extubated,O
106621,and,O
106621,transferred,O
106621,out,O
106621,of,O
106621,the,O
106621,MICU,O
106621,.,O
106621,Gram,O
106621,(,O
106621,+,O
106621,),O
106621,cocci,O
106621,growing,O
106621,from,O
106621,blood,O
106621,.,O
106621,.,O
106621,#,O
106621,#,O
106621,ID,O
106621,:,O
106621,-,O
106621,[,O
106621,**1-24**,O
106621,],O
106621,blood,O
106621,culture,O
106621,bottles,O
106621,from,O
106621,admission,O
106621,grew,B-Reason
106621,vanc-sensitive,I-Reason
106621,coag,I-Reason
106621,negative,I-Reason
106621,Staph,I-Reason
106621,;,I-Reason
106621,he,O
106621,completed,O
106621,a,O
106621,10-day,B-Duration
106621,course,O
106621,of,O
106621,IV,O
106621,vancomycin,B-Drug
106621,and,O
106621,remained,O
106621,afebrile,O
106621,-,O
106621,sputum,O
106621,culture,O
106621,grew,O
106621,non-Pseudomonas,B-Reason
106621,gram,I-Reason
106621,negative,I-Reason
106621,rods,I-Reason
106621,(,O
106621,CXR,O
106621,normal,O
106621,),O
106621,;,O
106621,completed,O
106621,course,O
106621,of,O
106621,levofloxacin,B-Drug
106621,-,O
106621,ceftriaxone,B-Drug
106621,was,O
106621,added,O
106621,for,B-Duration
106621,3,I-Duration
106621,days,I-Duration
106621,(,O
106621,[,O
106621,**Date,O
106621,range,O
106621,(,O
106621,1,O
106621,),O
106621,18881**,O
106621,],O
106621,),O
106621,due,O
106621,to,O
106621,concern,O
106621,for,O
106621,meningitis,B-Reason
106621,with,O
106621,his,O
106621,second,O
106621,change,O
106621,in,O
106621,mental,O
106621,status,O
106621,(,O
106621,see,O
106621,below,O
106621,),O
106621,and,O
106621,was,O
106621,stopped,O
106621,once,O
106621,mental,O
106621,status,O
106621,returned,O
106621,to,O
106621,baseline,O
106621,and,O
106621,it,O
106621,became,O
106621,clear,O
106621,there,O
106621,was,O
106621,no,O
106621,meningitis,O
106621,.,O
106621,#,O
106621,Mental,B-ADE
106621,status,I-ADE
106621,change,I-ADE
106621,:,I-ADE
106621,-On,O
106621,the,O
106621,night,O
106621,of,O
106621,[,O
106621,**9-3**,O
106621,],O
106621,",",O
106621,the,O
106621,patient,O
106621,became,O
106621,acutely,O
106621,psychotic,O
106621,and,O
106621,agitated,O
106621,.,O
106621,He,O
106621,was,O
106621,very,O
106621,worried,O
106621,that,O
106621,people,O
106621,were,O
106621,smoking,O
106621,crack,O
106621,in,O
106621,the,O
106621,halls,O
106621,and,O
106621,that,O
106621,there,O
106621,were,O
106621,people,O
106621,trying,O
106621,to,O
106621,hurt,O
106621,the,O
106621,nurses,O
106621,and,O
106621,sabotage,O
106621,Dr,O
106621,[,O
106621,**Name,O
106621,(,O
106621,NI,O
106621,),O
106621,6168**,O
106621,],O
106621,practice,O
106621,.,O
106621,His,O
106621,warfarin,B-Drug
106621,and,O
106621,steroids,B-Drug
106621,were,O
106621,stopped,O
106621,at,O
106621,this,O
106621,time,O
106621,.,O
106621,A,O
106621,psych,O
106621,consult,O
106621,was,O
106621,obtained,O
106621,the,O
106621,next,O
106621,morning,O
106621,who,O
106621,recommended,O
106621,Haldol/,B-Drug
106621,Cogentin,O
106621,.,O
106621,He,O
106621,required,O
106621,sedation,B-Reason
106621,with,O
106621,Haldol/,B-Drug
106621,Ativan/,O
106621,Dilaudid,B-Drug
106621,to,O
106621,get,O
106621,a,O
106621,head,O
106621,CT,O
106621,(,O
106621,which,O
106621,was,O
106621,negative,O
106621,for,O
106621,a,O
106621,bleed,O
106621,),O
106621,.,O
106621,Following,O
106621,sedation,O
106621,",",O
106621,the,O
106621,next,O
106621,evening,O
106621,",",O
106621,he,O
106621,was,O
106621,noted,O
106621,to,O
106621,be,O
106621,very,O
106621,rigid,B-Reason
106621,and,O
106621,received,O
106621,an,O
106621,additional,O
106621,dose,O
106621,of,O
106621,Cogentin,B-Drug
106621,.,I-Drug
106621,A,O
106621,neuro,O
106621,consult,O
106621,was,O
106621,obtained,O
106621,the,O
106621,next,O
106621,day,O
106621,who,O
106621,recommended,O
106621,stopping,O
106621,Haldol,B-Drug
106621,due,O
106621,to,O
106621,the,O
106621,rigidity,B-ADE
106621,.,I-ADE
106621,Per,O
106621,neuro,O
106621,consult,O
106621,",",O
106621,an,O
106621,LP,O
106621,was,O
106621,attempted,O
106621,twice,O
106621,to,O
106621,rule,O
106621,out,O
106621,CNS,O
106621,infection,O
106621,",",O
106621,but,O
106621,the,O
106621,patient,O
106621,was,O
106621,too,O
106621,agitated,O
106621,;,O
106621,he,O
106621,was,O
106621,treated,O
106621,empirically,O
106621,with,O
106621,vanco/,B-Drug
106621,ceftriaxone,O
106621,until,O
106621,it,O
106621,was,O
106621,clear,O
106621,that,O
106621,there,O
106621,was,O
106621,no,O
106621,meningitis,O
106621,;,O
106621,he,O
106621,had,O
106621,a,O
106621,persistently,O
106621,non-focal,O
106621,neuro,O
106621,exam,O
106621,with,O
106621,no,O
106621,menigeal,O
106621,signs,O
106621,.,O
106621,An,O
106621,EEG,O
106621,showed,O
106621,nonspecific,O
106621,slowing,O
106621,consistent,O
106621,with,O
106621,his,O
106621,sedation,O
106621,.,O
106621,Infectious,O
106621,workup,O
106621,(,O
106621,CXRs,O
106621,",",O
106621,cultures,O
106621,),O
106621,remained,O
106621,negative,O
106621,and,O
106621,he,O
106621,remained,O
106621,afebrile,O
106621,.,O
106621,His,O
106621,mental,O
106621,status,O
106621,slowly,O
106621,returned,O
106621,to,O
106621,baseline,O
106621,overnight,O
106621,on,O
106621,[,O
106621,**2171-9-6**,O
106621,],O
106621,",",O
106621,presumably,O
106621,as,O
106621,the,O
106621,effects,O
106621,of,O
106621,the,O
106621,steorids,B-Drug
106621,wore,O
106621,off,O
106621,.,O
106621,He,O
106621,was,O
106621,taken,O
106621,off,O
106621,of,O
106621,1:1,O
106621,observation,O
106621,and,O
106621,remained,O
106621,calm,O
106621,and,O
106621,cooperative,O
106621,.,O
106621,Further,O
106621,psychoactive,B-Drug
106621,meds,I-Drug
106621,(,O
106621,except,O
106621,for,O
106621,pain,B-Drug
106621,control,I-Drug
106621,meds,I-Drug
106621,),I-Drug
106621,were,O
106621,held,O
106621,.,O
106621,.,O
106621,#,O
106621,#,O
106621,Multiple,B-Reason
106621,myeloma,I-Reason
106621,:,I-Reason
106621,Currently,O
106621,on,O
106621,Velcade,B-Drug
106621,",",I-Drug
106621,last,O
106621,dose,O
106621,10/6,O
106621,",",O
106621,and,O
106621,dexamethasone,B-Drug
106621,.,I-Drug
106621,-,O
106621,he,O
106621,was,O
106621,continued,O
106621,on,O
106621,his,O
106621,outpatient,O
106621,dexamethasone,B-Drug
106621,regimen,O
106621,(,O
106621,8mg,B-Strength
106621,po,O
106621,bid,B-Frequency
106621,),I-Frequency
106621,but,O
106621,this,O
106621,was,O
106621,stopped,O
106621,on,O
106621,[,O
106621,**9-6**,O
106621,],O
106621,when,O
106621,he,O
106621,developed,O
106621,psychosis,B-ADE
106621,;,I-ADE
106621,there,O
106621,were,O
106621,some,O
106621,indications,O
106621,that,O
106621,he,O
106621,might,O
106621,not,O
106621,have,O
106621,been,O
106621,taking,O
106621,this,O
106621,at,O
106621,home,O
106621,",",O
106621,and,O
106621,his,O
106621,self-limited,B-ADE
106621,psychosis,I-ADE
106621,was,O
106621,thought,O
106621,to,O
106621,be,O
106621,secondary,O
106621,to,O
106621,the,O
106621,steroids,B-Drug
106621,.,O
106621,#,O
106621,#,O
106621,?,O
106621,DI/endocrine,B-Reason
106621,:,I-Reason
106621,-,O
106621,during,O
106621,previous,O
106621,admission,O
106621,there,O
106621,was,O
106621,a,O
106621,reported,O
106621,history,O
106621,of,O
106621,diabetes,O
106621,insipidus,O
106621,;,O
106621,a,O
106621,water,O
106621,deprivation,O
106621,test,O
106621,was,O
106621,done,O
106621,during,O
106621,that,O
106621,admission,O
106621,",",O
106621,though,O
106621,endocrine,O
106621,did,O
106621,not,O
106621,see,O
106621,the,O
106621,patient,O
106621,.,O
106621,Endocrine,O
106621,was,O
106621,consulted,O
106621,this,O
106621,time,O
106621,and,O
106621,recommended,O
106621,a,O
106621,pituitary,O
106621,MRI,O
106621,which,O
106621,showed,O
106621,a,O
106621,lack,O
106621,of,O
106621,expected,O
106621,hyperintensity,O
106621,in,O
106621,the,O
106621,neurohypophysis,O
106621,.,O
106621,No,O
106621,water,O
106621,deprivatino,O
106621,test,O
106621,was,O
106621,done,O
106621,",",O
106621,though,O
106621,his,O
106621,ddAVP,B-Drug
106621,was,O
106621,stopped,O
106621,when,O
106621,he,O
106621,became,O
106621,psychotic,B-ADE
106621,and,O
106621,his,O
106621,sodium,O
106621,remained,O
106621,normal,O
106621,with,O
106621,normal,O
106621,urine,O
106621,output,O
106621,.,O
106621,Per,O
106621,endo,O
106621,",",O
106621,he,O
106621,does,O
106621,not,O
106621,need,O
106621,to,O
106621,be,O
106621,on,O
106621,ddAVP,B-Drug
106621,.,I-Drug
106621,Also,O
106621,noted,O
106621,were,O
106621,low,O
106621,TSH,O
106621,",",O
106621,T4,O
106621,",",O
106621,T3,O
106621,",",O
106621,fT4,O
106621,levels,O
106621,.,O
106621,A,O
106621,rT3,O
106621,was,O
106621,slightly,O
106621,high,O
106621,and,O
106621,endocrine,O
106621,recommended,O
106621,repeat,O
106621,thyroid,O
106621,functino,O
106621,tests,O
106621,in,O
106621,[,O
106621,**12-26**,O
106621,],O
106621,weeks,O
106621,(,O
106621,suspect,O
106621,sick,O
106621,euthyroid,O
106621,),O
106621,for,O
106621,follow-up,O
106621,with,O
106621,no,O
106621,thyroid,O
106621,replacement,O
106621,at,O
106621,this,O
106621,time,O
106621,.,O
106621,.,O
106621,#,O
106621,#,O
106621,Obstructive/restrictive,B-Reason
106621,lung,I-Reason
106621,disease,I-Reason
106621,:,I-Reason
106621,Unclear,O
106621,etiology,O
106621,.,O
106621,MRI,O
106621,chest,O
106621,showed,O
106621,no,O
106621,PE,O
106621,and,O
106621,PA,O
106621,hypertension,O
106621,-,O
106621,continued,O
106621,Advair,B-Drug
106621,-,O
106621,weaned,O
106621,off,O
106621,of,O
106621,O2,O
106621,as,O
106621,tolerated,O
106621,.,O
106621,#,O
106621,#,O
106621,PAF,B-Reason
106621,:,I-Reason
106621,Currently,O
106621,rate-controlled,O
106621,.,O
106621,-,O
106621,cont,O
106621,metoprolol,B-Drug
106621,and,O
106621,short-acting,O
106621,diltiazem,B-Drug
106621,for,O
106621,rate,B-Reason
106621,control,I-Reason
106621,-,O
106621,warfarin,B-Drug
106621,was,O
106621,stopped,O
106621,due,O
106621,to,O
106621,mental,O
106621,status,O
106621,changes,O
106621,;,O
106621,with,O
106621,his,O
106621,continued,O
106621,gait,O
106621,instability,O
106621,",",O
106621,it,O
106621,was,O
106621,deemed,O
106621,too,O
106621,unsafe,O
106621,for,O
106621,him,O
106621,to,O
106621,continue,O
106621,warfarin,B-Drug
106621,",",I-Drug
106621,especially,O
106621,since,O
106621,he,O
106621,was,O
106621,not,O
106621,in,O
106621,AFib,O
106621,at,O
106621,all,O
106621,during,O
106621,the,O
106621,admisison,O
106621,.,O
106621,#,O
106621,#,O
106621,Endocrine,O
106621,-,O
106621,dexamethasone,B-Drug
106621,as,O
106621,above,O
106621,-,O
106621,TSH,O
106621,",",O
106621,T4,O
106621,",",O
106621,fT4,O
106621,all,O
106621,low,O
106621,;,O
106621,?,O
106621,sick,O
106621,euthyroid,O
106621,.,O
106621,#,O
106621,#,O
106621,Hypertension,B-Reason
106621,:,I-Reason
106621,-,O
106621,continued,O
106621,on,O
106621,his,O
106621,metoprolol,B-Drug
106621,and,O
106621,diltiazem,B-Drug
106621,.,O
106621,#,O
106621,#,O
106621,FEN,B-Reason
106621,:,I-Reason
106621,Poor,O
106621,po,O
106621,intake,O
106621,x,O
106621,weeks,O
106621,per,O
106621,sister,O
106621,;,O
106621,NPO,O
106621,in,O
106621,MICU,O
106621,-,O
106621,500cc,B-Dosage
106621,NS,O
106621,bolus,B-Dosage
106621,then,O
106621,NS,B-Drug
106621,at,O
106621,125cc/hr,B-Strength
106621,;,I-Strength
106621,check,O
106621,fluid,O
106621,status,O
106621,closely,O
106621,-,O
106621,daily,O
106621,lytes,O
106621,;,O
106621,watch,O
106621,for,O
106621,rising,O
106621,sodium,O
106621,-,O
106621,dysphagia,O
106621,diet,O
106621,",",O
106621,thickened,O
106621,liquids,O
106621,;,O
106621,may,O
106621,need,O
106621,speech/swallow,O
106621,eval,O
106621,.,O
106621,#,O
106621,#,O
106621,Code,O
106621,status,O
106621,:,O
106621,with,O
106621,his,O
106621,psychosis,O
106621,",",O
106621,he,O
106621,was,O
106621,made,O
106621,DNR/DNI,O
106621,by,O
106621,his,O
106621,sister,O
106621,(,O
106621,due,O
106621,to,O
106621,his,O
106621,advanced,O
106621,myeloma,O
106621,),O
106621,when,O
106621,he,O
106621,did,O
106621,not,O
106621,have,O
106621,capacity,O
106621,to,O
106621,make,O
106621,medical,O
106621,decisions,O
106621,.,O
106621,#,O
106621,#,O
106621,Communication,O
106621,:,O
106621,sister,O
106621,[,O
106621,**Name,O
106621,(,O
106621,NI,O
106621,),O
106621,18882**,O
106621,],O
106621,[,O
106621,**Name,O
106621,(,O
106621,NI,O
106621,),O
106621,634**,O
106621,],O
106621,(,O
106621,[,O
106621,**Telephone/Fax,O
106621,(,O
106621,1,O
106621,),O
106621,18883**,O
106621,],O
106621,.,O
106621,#,O
106621,#,O
106621,Dispo,O
106621,:,O
106621,pt,O
106621,is,O
106621,deconditioned,O
106621,and,O
106621,unsteady,O
106621,on,O
106621,his,O
106621,feet,O
106621,and,O
106621,",",O
106621,per,O
106621,primary,O
106621,team,O
106621,and,O
106621,PT,O
106621,",",O
106621,needs,O
106621,rehab,O
106621,Medications,O
106621,on,O
106621,Admission,O
106621,:,O
106621,Atorvastatin,B-Drug
106621,20,O
106621,mg,O
106621,qd,B-Frequency
106621,Diltiazem,O
106621,SR,O
106621,240,B-Strength
106621,mg,I-Strength
106621,Capsule,O
106621,qd,B-Frequency
106621,OxyContin,O
106621,20,B-Strength
106621,mg,I-Strength
106621,Q12H,O
106621,ddAVP,B-Drug
106621,[,O
106621,**Hospital1,O
106621,**,O
106621,],O
106621,Dexamethasone,B-Drug
106621,8,O
106621,mg,O
106621,[,O
106621,**Hospital1,O
106621,**,O
106621,],O
106621,Metoprolol,B-Drug
106621,100mg,O
106621,tid,B-Frequency
106621,Warfarin,O
106621,2.5mg,B-Strength
106621,qd,O
106621,Advair,B-Drug
106621,250-50mcg,O
106621,[,O
106621,**Hospital1,O
106621,**,O
106621,],O
106621,Oxycodone,B-Drug
106621,prn,O
106621,Albuterol,B-Drug
106621,MDI,O
106621,prn,B-Frequency
106621,Atrovent,O
106621,MDI,B-Form
106621,prn,O
106621,Senna,B-Drug
106621,prn,O
106621,Discharge,O
106621,Medications,O
106621,:,O
106621,1,O
106621,.,O
106621,Albuterol,B-Drug
106621,90,O
106621,mcg/Actuation,O
106621,Aerosol,B-Form
106621,Sig,O
106621,:,O
106621,1-2,B-Dosage
106621,Puffs,O
106621,Inhalation,B-Route
106621,every,O
106621,4-6,O
106621,hours,O
106621,as,O
106621,needed,O
106621,for,O
106621,shortness,B-Reason
106621,of,I-Reason
106621,breath,I-Reason
106621,or,O
106621,wheezing,B-Reason
106621,.,I-Reason
106621,2,O
106621,.,O
106621,Ipratropium,B-Drug
106621,Bromide,I-Drug
106621,17,O
106621,mcg/Actuation,O
106621,Aerosol,B-Form
106621,Sig,O
106621,:,O
106621,Two,B-Dosage
106621,(,I-Dosage
106621,2,I-Dosage
106621,),I-Dosage
106621,Puff,O
106621,Inhalation,B-Route
106621,Q4H,O
106621,(,O
106621,every,O
106621,4,O
106621,hours,O
106621,),O
106621,as,O
106621,needed,O
106621,for,O
106621,shortness,B-Reason
106621,of,I-Reason
106621,breath,I-Reason
106621,or,O
106621,wheezing,B-Reason
106621,.,I-Reason
106621,3,O
106621,.,O
106621,Docusate,B-Drug
106621,Sodium,I-Drug
106621,100,O
106621,mg,O
106621,Capsule,B-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Capsule,O
106621,PO,B-Route
106621,BID,O
106621,(,O
106621,2,O
106621,times,O
106621,a,O
106621,day,O
106621,),O
106621,.,O
106621,4,O
106621,.,O
106621,Oxycodone,B-Drug
106621,20,O
106621,mg,O
106621,Tablet,B-Form
106621,Sustained,I-Form
106621,Release,I-Form
106621,12HR,I-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Tablet,O
106621,Sustained,O
106621,Release,O
106621,12HR,O
106621,PO,B-Route
106621,Q12H,O
106621,(,O
106621,every,O
106621,12,O
106621,hours,O
106621,),O
106621,:,O
106621,give,O
106621,with,O
106621,10mg,B-Strength
106621,tablet,O
106621,for,O
106621,total,O
106621,dose,O
106621,of,O
106621,30mg,B-Strength
106621,q12h,O
106621,.,O
106621,5,O
106621,.,O
106621,Oxycodone,B-Drug
106621,10,O
106621,mg,O
106621,Tablet,B-Form
106621,Sustained,I-Form
106621,Release,I-Form
106621,12HR,I-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Tablet,O
106621,Sustained,O
106621,Release,O
106621,12HR,O
106621,PO,B-Route
106621,twice,O
106621,a,O
106621,day,O
106621,:,O
106621,give,O
106621,with,O
106621,20mg,B-Strength
106621,tablet,O
106621,for,O
106621,total,O
106621,dose,O
106621,of,O
106621,30mg,B-Strength
106621,q12h,O
106621,.,O
106621,6,O
106621,.,O
106621,Toprol,B-Drug
106621,XL,I-Drug
106621,100,O
106621,mg,O
106621,Tablet,B-Form
106621,Sustained,I-Form
106621,Release,I-Form
106621,24HR,I-Form
106621,Sig,O
106621,:,O
106621,Three,B-Dosage
106621,(,I-Dosage
106621,3,I-Dosage
106621,),I-Dosage
106621,Tablet,O
106621,Sustained,O
106621,Release,O
106621,24HR,O
106621,PO,B-Route
106621,once,O
106621,a,O
106621,day,O
106621,.,O
106621,7,O
106621,.,O
106621,Fentanyl,B-Drug
106621,50,O
106621,mcg/hr,O
106621,Patch,B-Form
106621,72HR,I-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Patch,O
106621,72HR,O
106621,Transdermal,B-Route
106621,Q72H,O
106621,(,O
106621,every,O
106621,72,O
106621,hours,O
106621,),O
106621,.,O
106621,8,O
106621,.,O
106621,Senna,B-Drug
106621,8.6,O
106621,mg,O
106621,Tablet,B-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Tablet,O
106621,PO,B-Route
106621,BID,O
106621,(,O
106621,2,O
106621,times,O
106621,a,O
106621,day,O
106621,),O
106621,as,O
106621,needed,O
106621,for,O
106621,constipation,B-Reason
106621,.,I-Reason
106621,9,O
106621,.,O
106621,Diltiazem,B-Drug
106621,HCl,I-Drug
106621,30,O
106621,mg,O
106621,Tablet,B-Form
106621,Sig,O
106621,:,O
106621,One,B-Dosage
106621,(,I-Dosage
106621,1,I-Dosage
106621,),I-Dosage
106621,Tablet,O
106621,PO,B-Route
106621,QID,O
106621,(,O
106621,4,O
106621,times,O
106621,a,O
106621,day,O
106621,),O
106621,:,O
106621,hold,O
106621,for,O
106621,HR,O
106621,<,O
106621,55,O
106621,",",O
106621,SBP,O
106621,<,O
106621,100,O
106621,.,O
106621,10,O
106621,.,O
106621,Oxycodone,B-Drug
106621,5,O
106621,mg,O
106621,Tablet,B-Form
106621,Sig,O
106621,:,O
106621,1-2,B-Dosage
106621,Tablets,O
106621,PO,B-Route
106621,every,O
106621,4-6,O
106621,hours,O
106621,as,O
106621,needed,O
106621,for,O
106621,pain,B-Reason
106621,.,I-Reason
106621,Discharge,O
106621,Disposition,O
106621,:,O
106621,Extended,O
106621,Care,O
106621,Facility,O
106621,:,O
106621,[,O
106621,**Hospital1,O
106621,**,O
106621,],O
106621,Senior,O
106621,Living,O
106621,Discharge,O
106621,Diagnosis,O
106621,:,O
106621,Primary,O
106621,diagnosis,O
106621,:,O
106621,change,O
106621,in,O
106621,mental,O
106621,status,O
106621,",",O
106621,multiple,O
106621,myeloma,O
106621,",",O
106621,steroid,B-Drug
106621,psychosis,O
106621,Secondary,O
106621,diagnosis,O
106621,:,O
106621,paroxysmal,O
106621,atrial,O
106621,fibrillation,O
106621,",",O
106621,hypertension,O
106621,",",O
106621,osteoarthritis,O
106621,s/p,O
106621,bilateral,O
106621,knee,O
106621,replacements,O
106621,",",O
106621,restrictive,O
106621,and,O
106621,obstructive,O
106621,pulmonary,O
106621,disease,O
106621,Discharge,O
106621,Condition,O
106621,:,O
106621,stable,O
106621,Discharge,O
106621,Instructions,O
106621,:,O
106621,You,O
106621,were,O
106621,admitted,O
106621,to,O
106621,the,O
106621,hospital,O
106621,after,O
106621,an,O
106621,acute,O
106621,change,O
106621,in,O
106621,your,O
106621,mental,O
106621,status,O
106621,which,O
106621,required,O
106621,intubation,O
106621,in,O
106621,order,O
106621,to,O
106621,protect,O
106621,your,O
106621,airway,O
106621,.,O
106621,After,O
106621,you,O
106621,were,O
106621,extubated,O
106621,",",O
106621,you,O
106621,were,O
106621,sent,O
106621,from,O
106621,the,O
106621,intensive,O
106621,care,O
106621,unit,O
106621,to,O
106621,the,O
106621,floor,O
106621,.,O
106621,While,O
106621,on,O
106621,the,O
106621,floor,O
106621,",",O
106621,you,O
106621,again,O
106621,had,O
106621,an,O
106621,abrupt,O
106621,change,O
106621,in,O
106621,your,O
106621,mental,O
106621,status,O
106621,where,O
106621,you,O
106621,were,O
106621,hallucinating,B-ADE
106621,and,O
106621,feeling,O
106621,very,O
106621,paranoid,B-ADE
106621,;,I-ADE
106621,it,O
106621,is,O
106621,thought,O
106621,that,O
106621,this,O
106621,was,O
106621,due,O
106621,to,O
106621,your,O
106621,high,O
106621,steroid,B-Drug
106621,dose,O
106621,which,O
106621,has,O
106621,since,O
106621,been,O
106621,stopped,O
106621,.,O
106621,Your,O
106621,warfarin,B-Drug
106621,(,O
106621,Coumadin,B-Drug
106621,),I-Drug
106621,has,O
106621,been,O
106621,stopped,O
106621,due,O
106621,to,O
106621,bleeding,B-ADE
106621,risks,O
106621,.,O
106621,Your,O
106621,intranasal,B-Route
106621,ddAVP,O
106621,was,O
106621,stopped,O
106621,since,O
106621,we,O
106621,do,O
106621,not,O
106621,believe,O
106621,that,O
106621,you,O
106621,need,O
106621,it,O
106621,.,O
106621,You,O
106621,are,O
106621,being,O
106621,discharged,O
106621,to,O
106621,a,O
106621,rehab,O
106621,facility,O
106621,so,O
106621,that,O
106621,you,O
106621,may,O
106621,regain,O
106621,your,O
106621,strength,O
106621,.,O
106621,Please,O
106621,attend,O
106621,all,O
106621,follow-up,O
106621,appointments,O
106621,.,O
106621,Please,O
106621,take,O
106621,all,O
106621,medications,O
106621,as,O
106621,prescribed,O
106621,.,O
106621,Followup,O
106621,Instructions,O
106621,:,O
106621,Provider,O
106621,:,O
106621,[,O
106621,**First,O
106621,Name8,O
106621,(,O
106621,NamePattern2,O
106621,),O
106621,539**,O
106621,],O
106621,[,O
106621,**Last,O
106621,Name,O
106621,(,O
106621,NamePattern1,O
106621,),O
106621,9816**,O
106621,],O
106621,",",O
106621,RN,O
106621,Phone,O
106621,:,O
106621,[,O
106621,**Telephone/Fax,O
106621,(,O
106621,1,O
106621,),O
106621,3241**,O
106621,],O
106621,Date/Time,O
106621,:,O
106621,[,O
106621,**2167-9-15**,O
106621,],O
106621,11:00,O
106621,Provider,O
106621,:,O
106621,[,O
106621,**First,O
106621,Name11,O
106621,(,O
106621,Name,O
106621,Pattern1,O
106621,),O
106621,1730**,O
106621,],O
106621,[,O
106621,**Last,O
106621,Name,O
106621,(,O
106621,NamePattern4,O
106621,),O
106621,6175**,O
106621,],O
106621,",",O
106621,MD,O
106621,Phone,O
106621,:,O
106621,[,O
106621,**Telephone/Fax,O
106621,(,O
106621,1,O
106621,),O
106621,3237**,O
106621,],O
106621,Date/Time,O
106621,:,O
106621,[,O
106621,**2167-9-15**,O
106621,],O
106621,11:00,O
106621,Provider,O
106621,:,O
106621,[,O
106621,**First,O
106621,Name8,O
106621,(,O
106621,NamePattern2,O
106621,),O
106621,**,O
106621,],O
106621,[,O
106621,**Last,O
106621,Name,O
106621,(,O
106621,NamePattern1,O
106621,),O
106621,11755**,O
106621,],O
106621,",",O
106621,[,O
106621,**MD,O
106621,Number,O
106621,(,O
106621,3,O
106621,),O
106621,1240**,O
106621,],O
106621,:,O
106621,[,O
106621,**Telephone/Fax,O
106621,(,O
106621,1,O
106621,),O
106621,3237**,O
106621,],O
106621,Date/Time,O
106621,:,O
106621,[,O
106621,**2167-9-15**,O
106621,],O
106621,11:00,O
